Purgo’s Strategic
Path to Market

TRACTION

Business Milestones

2016 & 2017

Invented by Dustin Williams PhD Associate Professor at the University of Utah and Director of the Bone and Biofilm Research Lab and Nicholas Ashton PhD.

Secured and Executed the Exclusive License Agreement with University of Utah Research Foundation.

2018 & 2019

Raised $350,000 of seed capital.

Completed business plan.

Applied for DOD grant.

Started developing prototypes.

Implemented IP strategy.

2016 & 2017

Invented by Dustin Williams PhD Associate Professor at the University of Utah and Director of the Bone and Biofilm Research Lab and Nicholas Ashton PhD.

Secured and Executed the Exclusive License Agreement with University of Utah Research Foundation.

2018 & 2019

Raised $350,000 of seed capital.

Started developing prototypes.

Completed business plan.

Implemented IP strategy.

Applied for DOD grant.

2016 & 2017

Invented by Dustin Williams PhD Associate Professor at the University of Utah and Director of the Bone and Biofilm Research Lab and Nicholas Ashton PhD.

Secured and Executed the Exclusive License Agreement with University of Utah Research Foundation.

2018 & 2019

Raised $350,000 of seed capital.

Completed business plan.

Applied for DOD grant.

Started developing prototypes.

Implemented IP strategy.

2020

AWARDED $4,260,000 in funded grants from an RFP from the Department of Defense for pouch development for Wounded Warriors.

USPTO issued patent for “Therapeutic Delivery Device.”

Prior to issuance, Purgo filed three patent continuations for new innovations.

Began initial sheep study.

2021

Prototype completed USING all medical grade components.

Continued sheep studies to confirm the efficacy of the Pouch.

Raised $850,000 in ADDITIONAL funding through the sale of Series C Units.

2020

AWARDED $4,260,000 in funded grants from an RFP from the Department of Defense for pouch development for Wounded Warriors.

USPTO issued patent for “Therapeutic Delivery Device.”

Prior to issuance, Purgo filed three patent continuations for new innovations.

Began initial sheep study.

2021

Prototype completed USING all medical grade components.

Continued sheep studies to confirm the efficacy of the Pouch.

Raised $850,000 in ADDITIONAL funding through the sale of Series C Units.

Commercialization Path

Creating Value for Investors

2022

Completed

  • Commence FDA clearance process.
  • Initiated 60+ sheep study.
  • Filing additional patent applications.
  • Filing for FDA clearance.
  • Raising additional funds through grants.
  • Sale of additional equity.
  • Complete private placement of series C units.
  • Prepping for clinical trials.

2022
Completed
2023

  • Begin discussions with Medicare / Medicaid and private insurers to approve reimbursement for procedure to place and remove the Pouch.
  • Develop relationships with hospitals that could be direct payers for the Pouch.
  • Prepare clinical trials strategy for Pouch clearance from the FDA if necessary.
  • Prepare strategy and establish relationships with surgeons to participate in the clinical trials.
  • Clinical trials begin.

2023
2024

  • Clinical trials completed.
  • Obtain FDA clearance.
  • Obtain reimbursement codes from the AMA. ICD10 World Health Organization.
  • Obtain CPT codes from American Medical Association.
    Launch the Purgo Pouch for surgical use.

2024

Commercialization Path

Creating Value for Investors

2022

  • Commence FDA clearance process.
  • Initiated 60+ sheep study.
  • Filing additional patent applications.
  • Filing for FDA clearance.
  • Raising additional funds through grants.
  • Sale of additional equity.
  • Complete private placement of series C units.
  • Prepping for clinical trials.

2022
2023

  • Begin discussions with Medicare / Medicaid and private insurers to approve reimbursement for procedure to place and remove the Pouch.
  • Develop relationships with hospitals that could be direct payers for the Pouch.
  • Prepare clinical trials strategy for Pouch clearance from the FDA if necessary.
  • Prepare strategy and establish relationships with surgeons to participate in the clinical trials.
  • Clinical trials begin.

2023
2024

  • Clinical trials completed.
  • Obtain FDA clearance.
  • Obtain reimbursement codes from the AMA. ICE10 World Health Organization. (Develop Stratigy)
  • Obtain CPT codes from American Medical Association.
    Launch the Purgo Pouch for surgical use.

2024

Pathway